Deutsche Bank Aktiengesellschaft Downgrades LHC Group (NASDAQ:LHCG) to Hold

LHC Group (NASDAQ:LHCGGet Rating) was downgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a research note issued on Monday, The Fly reports.

Other equities analysts have also issued research reports about the company. William Blair lowered LHC Group from an “outperform” rating to a “market perform” rating in a research note on Tuesday, March 29th. Barclays boosted their price objective on LHC Group from $154.00 to $170.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 12th. Truist Financial downgraded LHC Group from a “buy” rating to a “hold” rating in a research report on Thursday, March 31st. Benchmark downgraded LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 30th. Finally, Royal Bank of Canada downgraded LHC Group from an “outperform” rating to a “sector perform” rating and dropped their target price for the stock from $172.00 to $170.00 in a research report on Monday, April 4th. Thirteen investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $166.20.

LHC Group stock opened at $167.03 on Monday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $5.29 billion, a P/E ratio of 45.39, a P/E/G ratio of 2.21 and a beta of 0.45. The business’s fifty day moving average is $149.76 and its two-hundred day moving average is $138.67. LHC Group has a 52 week low of $108.42 and a 52 week high of $223.63.

LHC Group (NASDAQ:LHCGGet Rating) last posted its quarterly earnings data on Wednesday, February 23rd. The health services provider reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.06). The business had revenue of $583.40 million during the quarter, compared to analyst estimates of $582.44 million. LHC Group had a return on equity of 10.72% and a net margin of 5.21%. LHC Group’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.40 EPS. On average, equities research analysts predict that LHC Group will post 5.76 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its holdings in LHC Group by 4.3% in the fourth quarter. BlackRock Inc. now owns 5,235,392 shares of the health services provider’s stock valued at $718,452,000 after purchasing an additional 214,388 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of LHC Group by 2.7% in the third quarter. Wellington Management Group LLP now owns 3,281,022 shares of the health services provider’s stock worth $514,825,000 after acquiring an additional 85,022 shares in the last quarter. Invesco Ltd. increased its holdings in shares of LHC Group by 20.2% in the fourth quarter. Invesco Ltd. now owns 1,303,802 shares of the health services provider’s stock worth $178,922,000 after acquiring an additional 219,148 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its holdings in shares of LHC Group by 45.7% in the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 971,349 shares of the health services provider’s stock worth $133,298,000 after acquiring an additional 304,456 shares in the last quarter. Finally, Alliancebernstein L.P. increased its holdings in shares of LHC Group by 1.3% in the third quarter. Alliancebernstein L.P. now owns 764,516 shares of the health services provider’s stock worth $119,960,000 after acquiring an additional 9,468 shares in the last quarter. Institutional investors and hedge funds own 91.30% of the company’s stock.

LHC Group Company Profile (Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

Featured Articles

The Fly logo

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.